Descriptive Epidemiology of a Specialized Consultation on ADHD in Adults at the Strasbourg University Hospital

Attention Deficit and Hyperactivity Disorder Clinical Trial

— Stras-TDA  

Official title:

Descriptive Epidemiology of a Specialized Consultation on Attention Deficit Hyperactivity Disorder in Adults at the Strasbourg University Hospital, and Evolution Analysis at One Year

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03601858
• Other study ID #: 7083
• Status: Recruiting
• Start date: June 1, 2018
• Est. completion date: June 2019

Study information

• Verified date: June 2018
• Source: University Hospital, Strasbourg, France
• Contact: Sébastien Weibel, MD
• Phone: 33 3 88 11 51 57
• Email: sebastien.weibel[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The main objective of this study is to carry out a descriptive study of the clinical and demographic characteristics of patients having consulted for a specialized opinion about ADHD in adults of the psychiatric service of the Strasbourg University Hospital.

The characteristics of patients were collected during the first consultation, by the psychiatrist, and analyzed retrospectively.

The secondary objective is to evaluate the evolution at one year in terms of follow-up, maintenance under medical treatment and perceived effects of it.

The patients who had a prescription for pharmacological treatment of ADHD were contacted between 9 and 15 months after the first consultation and responded to a questionnaire assessing the evolution.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 300
• Est. completion date: June 2019
• Est. primary completion date: June 2019
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age > 18

• Having a specialized consultation about ADHD in adults in the psychiatric service of the Strasbourg University Hospital

• Agree with the use of medical files from the consultation for medical research

Exclusion Criteria:

• Disgree with the use of medical files from the consultation for medical research

Related Conditions & MeSH terms

• Attention Deficit and Hyperactivity Disorder
• Attention Deficit Disorder with Hyperactivity
• Hyperkinesis

Locations

Country	Name	City	State
France	Service de Psychiatrie II	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hyperactivity Disorder	Measuring from the medical files of patients and questionnaire	Between 9 and 15 months after the first consultation, contact of patients and collection of data for the evolution at one year analyze